Heron Reports Positive Top-Line Results from Phase 2 Study of HTX-011; Impax Receives FDA Approval for Generic Version of Testred® C-III Print E-mail
By David Fowler   
Tuesday, 22 September 2015 19:43
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 22, 2015.   
Read more...
 
Data From New Studies of VIBATIV; CytRx Announces the Publication of its Positive Global Phase 2b Clinical Trial Print E-mail
By William Kent   
Monday, 21 September 2015 18:49
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 21, 2015.
Read more...
 
Aquinox Offers Added Exploratory Analyses from LEADERSHIP Phase 2 Trial; FDA Approves Octapharma’s NUWIQ® Print E-mail
By David Fowler   
Friday, 18 September 2015 19:30
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 18, 2015.
Read more...
 
FDA Grants Fast Track Designation to Can-Fite's CF102; Merck Provides Diabetes Portfolio Update Print E-mail
By William Kent   
Thursday, 17 September 2015 19:20
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 17, 2015.   
Read more...
 
Cellular Biomedicine Group to Present CAR-T Phase I Clinical Trial Data for Tumors; Idera Pharma Reports Presentation of New Intratumoral IMO-2125 Preclinical Data Print E-mail
By Marilyn Mullen   
Wednesday, 16 September 2015 18:51
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 16, 2015.      
Read more...
 
Vanda Announces FDA Acceptance for Review of NDA for Maintenance Treatment of Schizophrenia; XenoPort Announces Positive Phase 2 Study Results for XP23829 Print E-mail
By William Kent   
Tuesday, 15 September 2015 19:03
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 15, 2015.  
Read more...
 
Anthera Announces Termination of Blisibimod Partnership in Japan by Zenyaku; OxySure to Host Special Stockholder Meeting Print E-mail
By Marilyn Mullen   
Monday, 14 September 2015 19:03
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 14, 2015.  
Read more...
 
Orgenesis Featured in Special Report on Curing Diabetes; Arrhythmia Research Announces Extension of Supply Agreement with Blue Belt Print E-mail
By Josh Gee   
Thursday, 10 September 2015 22:59
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 10, 2015.
Read more...
 
iBio to Receive US Patent for Influenza Therapeutic; BrainStorm Reports Closing of Enrollment of NurOwn Print E-mail
By William Kent   
Tuesday, 11 August 2015 18:32
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 11, 2015.
Read more...
 
Collegium Announces FDA Advisory Committee Meeting for Xtampza ER; Intrexon and Synthetic Biologics Enter ECC to Develop Novel Biotherapeutics for Treatment of Phenylketonuria Print E-mail
By Josh Gee   
Monday, 10 August 2015 21:27
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 10, 2015.  
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 4 of 369

Newsletter